These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 37004045)

  • 1. Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma.
    Sun S; Deng M; Wen J; Chen X; Xu J; Liu Y; Wan H; Wang J; Yan L; He Y; Xu Y
    BMC Cancer; 2023 Mar; 23(1):292. PubMed ID: 37004045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
    Wu M; Wang Z; Zhang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients.
    Huang B; Han W; Sheng ZF; Shen GL
    Cancer Cell Int; 2020; 20():195. PubMed ID: 32508531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RARRES1 identified by comprehensive bioinformatic analysis and experimental validation as a promising biomarker in Skin Cutaneous Melanoma.
    Liu M; Bai R; Zhang G; Liu X; Wang Z; He K; Gan X; Zhou X; Yin P; Zheng Y; Wang G
    Sci Rep; 2024 Jun; 14(1):14113. PubMed ID: 38898266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma.
    Zhao S; Wen S; Liu H; Zhou Z; Liu Y; Zhong J; Xie J
    Front Surg; 2022; 9():917776. PubMed ID: 36034394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma.
    Long S; Xu J; Huang H
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2427-2447. PubMed ID: 37086280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment.
    Zhu X; Zeng Z; Chen M; Chen X; Hu D; Jiang W; Du M; Chen T; Chen T; Liao W; Zhang C; Qu Y; Pan W
    Dis Markers; 2023; 2023():8101837. PubMed ID: 36741909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.
    Fan Y; Liang X; Yu D
    Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma.
    Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
    Tian Q; Gao H; Zhao W; Zhou Y; Yang J
    Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1QA, C1QB, and GZMB are novel prognostic biomarkers of skin cutaneous melanoma relating tumor microenvironment.
    Liang Z; Pan L; Shi J; Zhang L
    Sci Rep; 2022 Nov; 12(1):20460. PubMed ID: 36443341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
    Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
    Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Expression of T-Box Transcription Factor Protein 21 (TBX21) in Skin Cutaneous Melanoma Predicts Better Prognosis: A Study Based on The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) Databases.
    Zhang X; Wen X; Feng N; Chen A; Yao S; Ding X; Zhang L
    Med Sci Monit; 2020 Jun; 26():e923087. PubMed ID: 32561704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of aberrantly methylated differentially expressed genes and validation of CDC6 in melanoma.
    Liao L; Han W; Shen Y; Shen G
    J Cancer Res Clin Oncol; 2024 Jul; 150(7):362. PubMed ID: 39052109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
    Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
    Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma.
    Lv Y; Yuan CH; Han LY; Huang GR; Ju LC; Chen LH; Han HY; Zhang C; Zeng LH
    Dis Markers; 2022; 2022():4091978. PubMed ID: 35607442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma.
    Zhao S; Zhu Y; Liu H; He X; Xie J
    J Transl Med; 2023 Nov; 21(1):801. PubMed ID: 37950289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and immune infiltration implications of SIGLEC9 in SKCM.
    Yang P; Jiang Y; Chen R; Yang J; Liu M; Huang X; Xu G; Hao R
    Diagn Pathol; 2024 Aug; 19(1):112. PubMed ID: 39153970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of GPR143 as a promising novel marker for the progression of skin cutaneous melanoma through bioinformatic analyses and cell experiments.
    Bai R; Yin P; Xing Z; Wu S; Zhang W; Ma X; Gan X; Liang Y; Zang Q; Lei H; Wei Y; Zhang C; Dai B; Zheng Y
    Apoptosis; 2024 Apr; 29(3-4):372-392. PubMed ID: 37945816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower Expression of GBP2 Associated With Less Immune Cell Infiltration and Poor Prognosis in Skin Cutaneous Melanoma (SKCM).
    Zhang S; Chen K; Zhao Z; Zhang X; Xu L; Liu T; Yu S
    J Immunother; 2022 Jul-Aug 01; 45(6):274-283. PubMed ID: 35543550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.